The gold nanocluster-assisted delivery of NGF targeting siRNA (GNC-siRNA) allowed efficient NGF gene silencing and pancreatic tumor treatment in subcutaneous, orthotopic, and patient-derived xenograft models. This evidence concerns the gene NGF and pancreatic neoplasm.